Start with its own history
At 20.64×, COR is 15.8% below its 9-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NYSE · CORMedical - DistributionUpdated Nov 4, 2026
Cencora, Inc. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
20.64×
15.8% belowthe 9-observation annual average
Share price354
÷Earnings per share17.15
Price and EPS in quote currency. Calculation details
Investors are paying 20.64 for every 1 of reported earnings per share.
P/E over time
2017 – 2026
Annual P/ESelected-period average 24.52×
3-year average28.41×3 positive annual observations
5-year average24.54×5 positive annual observations
10-year average24.52×9 positive annual observations
Peer median · TTM25.64×6 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2026 | 16.65× | -57.3% |
| Sep 30, 2025 | 38.97× | +31.6% |
| Sep 30, 2024 | 29.62× | +41.9% |
| Sep 30, 2023 | 20.88× | +25.7% |
| Sep 30, 2022 | 16.60× | +4.0% |
| Sep 30, 2021 | 15.97× | N/M |
| Sep 30, 2020 | N/M | N/M |
| Sep 30, 2019 | 20.23× | +65.9% |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Sep 30, 2018 | 12.19× | -75.4% |
| Sep 30, 2017 | 49.55× | +312.8% |
| Sep 30, 2016 | 12.00× | N/M |
| Sep 30, 2015 | N/M | N/M |
| Sep 30, 2014 | 63.36× | +95.0% |
| Sep 30, 2013 | 32.50× | +136.7% |
| Sep 30, 2012 | 13.73× | -4.6% |
| Sep 30, 2011 | 14.39× | +6.1% |
| Sep 30, 2010 | 13.57× | +1.2% |
| Sep 30, 2009 | 13.40× | -44.5% |
| Sep 30, 2008 | 24.14× | +36.5% |
| Sep 30, 2007 | 17.69× | -10.8% |
| Sep 30, 2006 | 19.82× | -23.1% |
| Sep 30, 2005 | 25.77× | +101.5% |
| Sep 30, 2004 | 12.79× | -4.4% |
| Sep 30, 2003 | 13.38× | -38.6% |
| Sep 30, 2002 | 21.78× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How COR compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 COR This stockCencora, Inc. | 20.64× |
 MCKMcKesson Corporation | 27.36× |
 CAHCardinal Health, Inc. | 36.03× |
 HSICHenry Schein, Inc. | 23.91× |
 SHPMYShanghai Pharmaceuticals Holding Co., Ltd | 12.13× |
 SHTDYSinopharm Group Co. Ltd. | 6.31× |
 YI111, Inc. | N/M |
 ACHAccendra Health, Inc. | N/M |
 SIG.AXSigma Healthcare Limited | 45.78× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does COR’s P/E tell you?
Compare like with like
The median of the 6 positive peer ratios above is 25.64×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take COR into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("COR", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 354 ÷ EPS 17.15 = 20.64×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
COR P/E ratio: common questions
The essentials behind the numbers.
Cencora, Inc.'s current P/E is 20.64× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.